Rationale: Inhaled corticosteroids are commonly prescribed to patients with chronic
obstructive pulmonary disease (COPD). Objectives: To examine whether these medications …

The efficacy, safety and positioning of inhaled corticosteroids (ICS) in the treatment of
patients with chronic obstructive pulmonary disease (COPD) is much debated, since it can …

Inhaled corticosteroids (ICS) might lower the risk of coronary heart disease (CHD) in patients
with chronic obstructive pulmonary disease (COPD). This study aimed to assess the …

PURPOSE We wanted to review systematically the efficacy, effectiveness, and safety of
inhaled corticosteroids with respect to health outcomes in patients with chronic obstructive …

Objectives Inhaled corticosteroids (ICS) reduce exacerbation rates and the decline in lung
function in people with chronic obstructive pulmonary disease (COPD). There is evidence …

Background Chronic lung diseases and drugs used to treat patients with chronic lung
diseases may be associated with an increased fracture risk. Methods The design was a case …

Background The use of inhaled corticosteroid (ICS) in patients with chronic obstructive
pulmonary disease (COPD) decreases the frequency of COPD exacerbations. Recently …

Background and objective The overprescription of inhaled corticosteroids (ICS) in the
current Global Initiative for Chronic Obstructive Lung Disease (GOLD) group A and B …

Inhaled corticosteroids (ICSs) are often prescribed in patients with chronic obstructive
pulmonary disease (COPD). Their impact on the risk of lung cancer, a leading cause of …

Chronic obstructive pulmonary disease (COPD) is a progressive disease with alveolar
destruction (emphysema) and bronchiolar fibrosis (obstructive bronchitis) in variable …